| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other expense, net | -75,567 | -59,661 | -62,861 | -73,386 |
| Income (loss) before income taxes | -5,223 | 51,711 | 37,486 | 15,423 |
| (benefit from) provision for income taxes | -23,355 | 16,101 | 12,868 | 3,666 |
| Net income (loss) | 18,132 | 35,610 | 24,618 | 11,757 |
| Basic (in dollars per share) | 0.01 | 0.07 | 0.04 | 0 |
| Basic (in shares) | 314,168,000 | 313,739,000 | 311,054,000 | 309,647,000 |
| Diluted (in dollars per share) | 0.01 | 0.07 | 0.04 | 0 |
| Diluted (in shares) | 324,754,000 | 322,363,000 | 323,961,000 | 309,647,000 |
Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. (AMRX)